# FYARRO
> **NDA213312** · New Drug Application · Sponsor: AADI · Approved 2021-11-22
## Drug
- **FDA Application Number:** NDA213312
- **Application type:** New Drug Application
- **Brand name:** FYARRO
- **Generic name:** SIROLIMUS
- **Active ingredients:** SIROLIMUS
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AADI
- **Manufacturer:** Aadi Bioscience, Inc.
- **First approval:** 2021-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213312)
---
*MORVS · CC0 1.0*